Medical/Pharmaceuticals

Listen to Your Body with the Newly-launched Amazfit PowerBuds Pro; TWS Earbuds with Advanced Health Monitoring Features

CUPERTINO, Calif., July 13, 2021 /PRNewswire/ -- Today, Amazfit , a brand of Zepp Health (NYSE: ZEPP), launched the Amazfit PowerBuds Pro - their new true wireless stereo (TWS) earbuds with advanced health monitoring features and powerful multi-scenario active noise ...

2021-07-13 21:00 19110

Global consulting firm Star acquires Pro4People, creating powerhouse in MedTech development and regulatory consulting

WROCLAW, Poland, July 13, 2021 /PRNewswire/ -- Star, a global technology company connecting end-to-end strategy, design and engineering services, announced its acquisition of Pro4People, a leading software consultancy based in Wroclaw,Poland, specializing in regulated MedTech and Digital Healthca...

2021-07-13 20:59 2707

Seegene Introduces New SARS-CoV-2 Variants Detection Test That Can Screen Six Virus Variants Including the Delta and Delta Plus

* Seegene launches new multiplex PCR test capable of screening six SARS-CoV-2 variants including the Delta and Delta Plus variants attributable for a recent surge in global COVID-19 cases. * The new CE-IVD marked variants detection kit to differentiate 10 major COVID-19 variants including the...

2021-07-13 20:00 2408

Everest Medicines Announces Strategic Collaboration with Medbanks Health Technology to Develop Innovative Healthcare Service Solutions for Patients in China

SHANGHAI, July 13, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater C...

2021-07-13 19:47 7553

Zepp Health Introduces Next Gen Smart Wearable Chip, Smartwatch OS and Blood Pressure Measurement at Annual Developers Conference

HEFEI, China, July 13, 2021 /PRNewswire/ -- Zepp Health Corp. (NYSE: ZEPP) today  hostedNext Beat 2021 – The Future of Heath, the company's annual developers conference, which included the announcement of several key company developments. Huangsha...

2021-07-13 19:41 17852

GenScript to Host Gene & Cell Engineering Virtual Summit

PISCATAWAY, N.J. , July 13, 2021 /PRNewswire/ -- GenScript® , the world's leading life science service provider, announced today the firstGenScript Gene & Cell Engineering Virtual Summit,

2021-07-13 19:30 49169

Nuctech™ Kylin Care Wins the German Red Dot Award, the "Oscar of the Design World"

BEIJING, July 12, 2021 /PRNewswire/ -- Recently, the German Red Dot Design Award, also known as the "Oscar of the design world", has been officially announced, and Nuctech has won the Red Dot: Best of the Best award, the top prize of Red Dot Award: Design Concept.

2021-07-13 11:30 2436

CD47 Monoclonal Antibody (AK117) Completed Phase I Dose Escalation Trial and Obtained Approval to Initiate Clinical Trial in Combination with Azacitidine for Treatment of Acute Myeloid Leukemia

HONG KONG, July 12, 2021 /PRNewswire/ -- Akeso, Inc. is pleased to announce that, CD47 monoclonal antibody (AK117), a second-generation novel drug for immuno-oncology therapy independently developed by the Company, has completed phase I dose escalation trial inAustralia. AK117 resulted in no dose...

2021-07-13 09:06 2610

Ascletis Announces Dosing of the First Cohort of Healthy Subjects in the FXR Agonist ASC42 Bridging Study for Chronic Hepatitis B Indication in China

--This bridging study to select doses for the Phase II trial in China in patients with chronic hepatitis B (CHB) --ASC42 clinical trials are being conducted in the U.S. and China for non-alcoholic steatohepatitis (NASH) and CHB. HANGZHOU and SHAOXING, China, July 13, 2021 /PRNewswire/ -- A...

2021-07-13 08:30 3877

Hochuen Medical Raises Tens of Millions RMB in Series A Financing

SHENZHEN, July 12, 2021 /PRNewswire/ -- Hochuen Medical Technology Co., Ltd. (hereinafter referred to as "Hochuen Medical") has raised a40 million Yuan (RMB) Series A round of financing led by Qiming Venture Partners as the sole investor. The new proceeds will be used to (1) accelerate the com...

2021-07-13 01:05 2365

Servier and Nymirum Announce Strategic Collaboration to Discover and Develop RNA-Targeted Small Molecule Therapeutics

PARIS, July 12, 2021 /PRNewswire/ -- Servier, a global independent pharmaceutical Group, and Nymirum, a pioneer in RNA-targeted small molecules, announced todaythat they have entered into a strategic collaboration to identify and develop RNA-modulatory drugs for the treatment of neurological ...

2021-07-12 23:00 1830

Werfen Companies Unite Under One Name And One Brand

BARCELONA, Spain, July 12, 2021 /PRNewswire/ -- Werfen today announced that its companies, including Instrumentation Laboratory (IL), Inova Diagnostics (Inova), and Biokit, are uniting under one name and one brand—Werfen. As part of this effort, the Company has completed organizational transition...

2021-07-12 20:00 2117

ProfoundBio Announces Completion of More Than $55 million Series A Financing to Advance Novel Antibody-Drug Conjugate (ADC) Portfolio

WOODINVILLE, Wash. and SUZHOU, China, July 12, 2021 /PRNewswire/ -- ProfoundBio announced the closing of a $55+ million Series A financing round led byLilly Asia Venture and co-led by LYFE Capital, with participation from Sequoia Capital China and Oriza.  All investors from the Series Pre-A finan...

2021-07-12 17:00 3474

Hummingbird Bioscience and MD Anderson Announce Strategic Research Collaboration To Advance Innovative Immunotherapies

HOUSTON and SINGAPORE, July 12, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to produce major improvements in treatment outcomes, andThe University of Texas MD Anderson Cancer Ce...

2021-07-12 17:00 1912

Stem cell therapy company Amniotics raises SEK 60 million before deduction of transaction costs, in First North IPO to advance lead candidate PulmoStem(TM) into clinic

Novel source of stem cells in full-term amniotic fluid provides basis for broad pipeline LUND, Sweden, July 12, 2021 /PRNewswire/ -- Amniotics AB (publ) ("Amniotics" or the "Company"), a stem cell therapy company has raisedSEK60 million through its recent listing on Nasdaq First North Growth Mar...

2021-07-12 14:00 3212

New Study Demonstrates Significantly Increased Healing Rates with NATROX® Oxygen Wound Therapy

Treatment offers hope for patients with long-standing chronic wounds CAMBRIDGE, England, July 12, 2021 /PRNewswire/ -- Inotec AMD, manufacturer of NATROX® Oxygen Wound Therapy, is delighted to share newly published randomised controlled trial (RCT) results[1]. The trial involved 145 patients with...

2021-07-12 13:00 1782

Everest Medicines Announces Strategic Commercial Partnership with Global Technology Company, Tencent

SHANGHAI, July 12, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater C...

2021-07-12 12:42 6013

LEAD Horizon: How Vienna gargles out of lockdown

VIENNA, July 12, 2021 /PRNewswire/ -- With the initiative "everything gargles" Vienna got through the pandemic better in comparison to other European cities. Every day, up to 70.000 people participate in the simple gargle PCR testing to inquire their Covid-19 status. Following the example ofVienn...

2021-07-12 08:30 3060

Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI323 (Anti-LAG-3/PD-L1 Bispecific Antibody) in Patients with Advanced Malignant Tumors

SAN FRANCISCO and SUZHOU, China, July 12, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...

2021-07-12 08:12 5412

Sciwind Biosciences Appoints Dr. Weidong Zhong as Chief Strategy Officer and President of its US Subsidiary

HANGZHOU, China and SAN FRANCISCO, July 12, 2021 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd., a clinical-stage, fast-growing biopharmaceutical company focusing on discovering and developing innovative therapies to treat chronic, metabolic and immunological diseases, announced today the...

2021-07-12 08:00 4067